vTv Therapeutics Inc.
02/27/2025 | Press release | Distributed by Public on 02/27/2025 15:14
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 24, 2025, Steven Tuch, Executive Vice President and Chief Financial Officer of vTv Therapeutics Inc. (the "Company"), informed the Company of his intention to resign from his position effective March 21, 2025. Mr. Tuch is expected to remain at the Company through the filing of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission. The Company has commenced efforts to identify Mr. Tuch's successor through an external search process. Mr. Tuch's departure is not based on any disagreement with the Company's independent auditors or the Company on any matter.